ANGLE plc (ANPCF)

USD 0.16

(0.0%)

Market Cap (In USD)

51.92 Million

Revenue (In USD)

2.18 Million

Net Income (In USD)

-20.13 Million

Avg. Volume

-

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.148-0.35
PE
-
EPS
-
Beta Value
0.255
ISIN
GB0034330679
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Mr. Andrew David William Newland ACA, Meng
Employee Count
-
Website
https://angleplc.com
Ipo Date
2014-01-23
Details
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD multiplex analysis system for routine and focused multiplex analysis of DNA, RNA or protein biomarkers. The company was founded in 1994 and is based in Guildford, the United Kingdom.